Skip to content

Randomised trial of rapid outpatient rehydration versus hospital admission for hyperemesis gravidarum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47846769
Enrollment
100
Registered
2008-06-30
Start date
2008-03-17
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperemesis gravidarum Pregnancy and Childbirth Excessive vomiting in pregnancy

Interventions

Comparison of conventional inpatient continuous intravenous rehydration for women with HG with daily attendance at the Acute Gynaecology Unit for rehydration over four hours. The same anti-emetic and

Sponsors

St George's Healthcare NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All pregnant women up to 20 weeks gestation referred to the Acute Gynaecology Unit with persistent vomiting and at least 1+ ketonuria.

Exclusion criteria

Exclusion criteria: 1. Women greater than 20 weeks gestation 2. Women with another medical condition manifesting as nausea and vomiting such as urinary tract infection (UTI) 3. Type 1 or 2 diabetes 4. Potassium less than 3.2 mmol/l 5. Sodium less than 130 mmol/l 6. Abnormal liver function tests (associated with increased severity of HG) 7. Abnormal thyroid function tests (associated with increased severity of HG)

Design outcomes

Primary

MeasureTime frame
A difference between the two groups in reduction in Pregnancy-Unique Quantification of Emesis (PUQE) score at 48 hours.

Secondary

MeasureTime frame
A difference between the two groups in: 1. Number of days intravenous fluid treatment needed 2. Number with ketonuria at 48 hours 3. Improvement, at two and seven days from start of treatment, in: 3.1. PUQE 3.2. Drinking and eating scores 3.3. Well-being rating 4. Weight change at seven days 5. Number still taking anti-emetics at one week following discharge 6. Re-attendance episodes for hyperemesis in the seven days following discharge 7. Costs of treatment

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026